Reference:
1. European Medicines Agency. PRAC recommends restricting use of domperidone. European Medicines Agency. 2014. Available from: https://www.ema.europa.eu
2. Simkó J, Lőrincz I. The cardiotoxicity of macrolides: the role of interactions. In: Mendez-Vilaz A, editor. Microbial pathogens and strategies for combating them: science, technology and education. Badajoz: Formatex Research Center; 2013. P.1941-9.
3. Health Science Authority, Singapore. New recommendations on the use of domperidone, 26 May 2017. Available from: https://www.hsa.gov.sg/content/hsa/en/Health_Products_Regulation/Safety_Information_and_Product_Recalls/Product_Safety_Alerts/2017/new-recommendationsontheuseofdomperidone.html
Keywords:
-